| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.670 | 15.805 | 13.665 | 15.319 | 23.972 | 16.375 | 14.776 |
| Total Income - EUR | - | - | - | 9.670 | 15.805 | 13.665 | 15.319 | 23.972 | 16.780 | 14.776 |
| Total Expenses - EUR | - | - | - | 3.506 | 2.125 | 6.295 | 3.940 | 4.288 | 10.660 | 17.288 |
| Gross Profit/Loss - EUR | - | - | - | 6.164 | 13.680 | 7.371 | 11.379 | 19.684 | 6.120 | -2.513 |
| Net Profit/Loss - EUR | - | - | - | 5.874 | 13.206 | 6.990 | 10.975 | 19.073 | 5.955 | -2.636 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Stetomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.358 | 910 | 1.205 | 1.463 | 4.587 | 2.762 |
| Current Assets | - | - | - | 6.052 | 17.748 | 25.328 | 35.575 | 54.379 | 22.695 | 25.921 |
| Inventories | - | - | - | 96 | 855 | 1.694 | 1.656 | 2.870 | 6.095 | 6.282 |
| Receivables | - | - | - | 3.251 | 4.004 | 6.409 | 11.579 | 47.952 | 16.152 | 15.144 |
| Cash | - | - | - | 2.704 | 12.889 | 17.226 | 22.339 | 3.557 | 448 | 4.495 |
| Shareholders Funds | - | - | - | 5.917 | 19.008 | 25.638 | 36.044 | 55.229 | 24.627 | 21.853 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 135 | 151 | 610 | 780 | 613 | 2.656 | 6.831 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Stetomed S.r.l.